Skip to main content
Clinical Trials/IRCT20210423051054N1
IRCT20210423051054N1
Not yet recruiting
Phase 3

Evaluation of therapeutic effect of placental mesenchymal stem cell exosome injection in improving clinical symptoms and MRI changes in patients with knee osteoarthritis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Knee osteoarthritis.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
30
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pain in both knees over the past 6 months, which is related to the degenerative process of the knee, requires pain medication and has lasted for more than a month.
  • Graphical confirmation of bilateral knee osteoarthritis with grade 2 or 3 based on the Kellgren\-Lawrence classification.
  • The knee pain intensity should be greater than or equal to 4 according to the VAS.

Exclusion Criteria

  • Younger than 45 years or older than 65 years
  • Rheumatic or collagen vascular disease
  • History of malignancy
  • Coagulopathy or taking anticoagulant drug
  • Any injection into the knee joint during the last 3 months
  • A history of recent severe knee trauma in the past 1 month
  • Septic arthritis of the knee or active wound of the knee joint
  • Genovarum or genovalgum greater than 20 degrees
  • Total knee replacement
  • Cardiac pacemaker

Outcomes

Primary Outcomes

Not specified

Similar Trials